Chemours Company Insiders
CC Stock | USD 26.62 0.25 0.95% |
About 75 percent of all Chemours' insiders are aggressively buying. The analysis of insiders' sentiment of trading Chemours Co stock suggests that quite a large number of insiders are very bullish at this time. Chemours employs about 6.2 K people. The company is managed by 40 executives with a total tenure of roughly 190 years, averaging almost 4.0 years of service per executive, having 155.0 employees per reported executive.
Mark Vergnano CEO President, Chief Executive Officer, Director |
Dawn Farrell Chairman Independent Chairman of the Board |
Chemours' Insider Buying Vs Selling
75
Selling | Buying |
Latest Trades
2023-08-09 | Michael C. Burgess | Acquired @ 35.6 | |||
2023-07-06 | Michael C. Burgess | Acquired @ 35.97 | |||
2023-06-09 | Mark Newman | Acquired 7661 @ 34.63 | View | ||
2023-06-08 | Matthew S Abbott | Disposed 8912 @ 34.2 | View |
Monitoring Chemours' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Chemours' insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Chemours Co. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Chemours' stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Chemours |
Chemours' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Chemours' future performance. Based on our forecasts, it is anticipated that Chemours will maintain a workforce of about 8100 employees by May 2024.Chemours' latest congressional trading
Congressional trading in companies like Chemours, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Chemours by those in governmental positions are based on the same information available to the general public.
2023-08-09 | Representative Michael C. Burgess | Acquired $15K to $50K | Verify | ||
2017-10-10 | Senator Tammy Duckworth | Acquired Under $15K | Verify |
Chemours Management Team Effectiveness
The company has Return on Asset (ROA) of 0.0529 % which means that for every $100 of assets, it generated a profit of $0.0529. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.2568) %, which implies that it produced no returns to current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.01. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 2.11, whereas Total Assets are forecasted to decline to about 7.5 B.As of April 18, 2024, Common Stock Shares Outstanding is expected to decline to about 140.1 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 355.7 M
Chemours Workforce Comparison
Chemours Co is rated third in number of employees category among related companies. The total workforce of Materials industry is currently estimated at about 118,288. Chemours holds roughly 6,200 in number of employees claiming about 5% of all equities under Materials industry.
Chemours Profit Margins
The company has Net Profit Margin (PM) of (0.04) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.07 %, which signifies that for every $100 of sales, it has a net operating income of $0.07.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.26 | 0.2175 |
|
|
Chemours Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemours insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemours' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Chemours insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.2727 | 3 | 11 | 21,103 | 17,440 |
2023-12-01 | 0.6667 | 4 | 6 | 6,234 | 23,102 |
2023-09-01 | 1.25 | 10 | 8 | 46,271 | 36,191 |
2023-06-01 | 0.7 | 14 | 20 | 77,578 | 117,039 |
2023-03-01 | 2.0 | 52 | 26 | 1,181,362 | 248,824 |
2022-12-01 | 0.25 | 2 | 8 | 1,225 | 48,199 |
2022-06-01 | 0.875 | 21 | 24 | 357,776 | 1,041,114 |
2022-03-01 | 1.45 | 29 | 20 | 586,847 | 56,067 |
2021-12-01 | 0.5 | 7 | 14 | 168,086 | 396,229 |
2021-09-01 | 0.5833 | 14 | 24 | 210,537 | 264,324 |
2021-06-01 | 2.0 | 12 | 6 | 84,289 | 92,694 |
2021-03-01 | 1.3913 | 32 | 23 | 718,907 | 88,590 |
2020-12-01 | 0.7778 | 7 | 9 | 282,214 | 388,035 |
2020-09-01 | 1.5 | 3 | 2 | 4,751 | 5,456 |
2020-06-01 | 12.0 | 12 | 1 | 107,816 | 289.00 |
2020-03-01 | 2.0909 | 23 | 11 | 1,785,590 | 527,189 |
2019-09-01 | 2.25 | 9 | 4 | 68,327 | 15,674 |
2019-06-01 | 2.4286 | 17 | 7 | 197,214 | 203,581 |
2019-03-01 | 1.4667 | 22 | 15 | 1,672,048 | 573,590 |
2018-09-01 | 0.1667 | 1 | 6 | 692.00 | 129,582 |
2018-06-01 | 0.8 | 12 | 15 | 264,547 | 520,190 |
2018-03-01 | 0.5714 | 12 | 21 | 218,147 | 100,765 |
2017-12-01 | 0.5625 | 9 | 16 | 88,761 | 144,463 |
2017-09-01 | 0.6 | 6 | 10 | 68,597 | 97,589 |
2017-06-01 | 1.6 | 16 | 10 | 72,787 | 77,111 |
2017-03-01 | 1.2 | 18 | 15 | 767,188 | 57,114 |
2016-12-01 | 1.0 | 2 | 2 | 1,649 | 18,989 |
2016-06-01 | 2.5 | 15 | 6 | 226,999 | 27,482 |
2016-03-01 | 0.619 | 13 | 21 | 1,168,026 | 53,045 |
2015-12-01 | 2.0 | 4 | 2 | 39,328 | 19,344 |
2015-09-01 | 33.0 | 66 | 2 | 2,883,943 | 116.00 |
2008-12-01 | 3.0 | 3 | 1 | 30,357,248 | 0.00 |
2008-06-01 | 1.9667 | 59 | 30 | 328,306 | 58,229 |
2007-09-01 | 24.0 | 24 | 1 | 300,465 | 0.00 |
2007-06-01 | 1.8571 | 78 | 42 | 94,188 | 48,545 |
2006-12-01 | 3.0 | 33 | 11 | 37,297 | 68,876 |
2006-09-01 | 1.0645 | 33 | 31 | 50,890 | 100,000 |
2006-06-01 | 0.5478 | 86 | 157 | 484,863 | 838,588 |
2006-03-01 | 0.5775 | 41 | 71 | 309,253 | 961,195 |
2005-12-01 | 6.6 | 33 | 5 | 42,188 | 10,417 |
2005-06-01 | 1.4348 | 66 | 46 | 944,550 | 509,897 |
2005-03-01 | 20.0 | 20 | 1 | 102.00 | 95,000 |
2004-12-01 | 4.6667 | 28 | 6 | 57,572 | 57,469 |
2004-06-01 | 1.375 | 33 | 24 | 92,933 | 56,501 |
2004-03-01 | 2.0 | 8 | 4 | 91.97 | 7,882 |
2003-12-01 | 5.0 | 10 | 2 | 32,925 | 32,841 |
2003-09-01 | 0.5385 | 7 | 13 | 83.11 | 301,477 |
Chemours Notable Stakeholders
A Chemours stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chemours often face trade-offs trying to please all of them. Chemours' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chemours' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Vergnano | President, Chief Executive Officer, Director | Profile | |
Dawn Farrell | Independent Chairman of the Board | Profile | |
Richard Brown | Independent Chairman of the Board | Profile | |
Bryan Snell | President - Titanium Technologies | Profile | |
Matthew Abbott | Vice President - Digital and Analytics Platforms Leader | Profile | |
David Shelton | Senior Vice President, General Counsel, Secretary | Profile | |
Paul Kirsch | President - Fluoroproducts | Profile | |
Christian Siemer | President - Chemical Solutions | Profile | |
Alisha Bellezza | President - Thermal & Specialized Solutions | Profile | |
Joseph Martinko | President Solutions | Profile | |
Susan Kelliher | Senior Vice President – Human Resources and Health Services | Profile | |
Gerardo Calderon | President Materials | Profile | |
Eugene Snell | President - Titanium Technologies | Profile | |
Thierry Vanlancker | President of Fluoroproducts | Profile | |
Sameer Ralhan | Chief Financial Officer, Senior Vice President, Treasurer | Profile | |
Mark Newman | Chief Operating Officer, Senior Vice President | Profile | |
Edwin Sparks | President - Chemical Solutions Business, Titanium Technologies | Profile | |
Erich Parker | Senior Vice President of Corporate Communications and Chief Brand Officer. | Profile | |
Elizabeth Albright | Sr. VP of HR | Profile | |
Curtis Anastasio | Independent Director | Profile | |
Stephen Newlin | Independent Director | Profile | |
Curtis Crawford | Independent Director | Profile | |
Mary Cranston | Independent Director | Profile | |
Bradley Bell | Independent Director | Profile | |
Erin Kane | Independent Director | Profile | |
Sean Keohane | Independent Director | Profile | |
Kristine Wellman | General VP | Profile | |
Jonathan Lock | Senior Vice President and Chief Development Officer | Profile | |
Amber Wellman | Chief Officer | Profile | |
Denise Dignam | President - Advanced Performance Materials | Profile | |
Aditya Beri | Interim Business | Profile | |
Sheryl Telford | Chief Sustainability Officer | Profile | |
Ron Charles | Senior People | Profile | |
Sandra Rogers | Independent Director | Profile | |
Kurt Bonner | Ma Relations | Profile | |
Guillaume Pepy | Independent Director | Profile | |
Brandon Ontjes | Vice Relations | Profile | |
Camela Wisel | Chief Accounting Officer, Vice President Controller | Profile | |
Lori Ursomarso | IR Contact Officer | Profile | |
Alvenia Scarborough | Senior Vice President - Corporate Communications and Chief Brand Officer | Profile |
About Chemours Management Performance
The success or failure of an entity such as Chemours often depends on how effective the management is. Chemours management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chemours management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chemours management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | (0.02) | (0.01) | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.32) | (0.31) |
The data published in Chemours' official financial statements usually reflect Chemours' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Chemours. For example, before you start analyzing numbers published by Chemours accountants, it's critical to develop an understanding of what Chemours' liquidity, profitability, and earnings quality are in the context of the Chemicals space in which it operates.
Please note, the presentation of Chemours' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Chemours' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chemours Co. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.
Chemours Workforce Analysis
Traditionally, organizations such as Chemours use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chemours within its industry.Chemours Manpower Efficiency
Return on Chemours Manpower
Revenue Per Employee | 972.1K | |
Revenue Per Executive | 150.7M | |
Net Loss Per Employee | 38.4K | |
Net Loss Per Executive | 6M | |
Working Capital Per Employee | 217.6K | |
Working Capital Per Executive | 33.7M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.